GSK.L: Summary for GLAXOSMITHKLINE PLC ORD 25P - Yahoo Finance

UK Markets open in 7 hrs 48 mins

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,560.50+9.00 (+0.58%)
At close: 5:06PM GMT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous close1,551.50
Bid1,550.00 x 175400
Ask1,580.00 x 417900
Day's range1,552.50 - 1,567.00
52-week range1,314.26 - 1,745.56
Avg. volume8,800,236
Market cap76.62B
PE ratio (TTM)255.82
Earnings dateN/A
Dividend & yield0.93 (4.73%)
Ex-dividend dateN/A
1y target estN/A
  • Financial Times2 hours ago

    [$$] Davos launches coalition to prevent epidemics of emerging viruses

    A billion-dollar global coalition will create new vaccines to protect the world against emerging viruses that could cause catastrophic epidemics. Bill Gates, one of the coalition's biggest backers through ...

  • Bloomberg2 hours ago

    Ebola, Zika Push Drugmakers to Join Effort to Avert Pandemics

    Spurred by the Ebola and Zika epidemics, GlaxoSmithKline Plc, Johnson & Johnson and Sanofi are among drugmakers backing an effort to develop new vaccines that could be deployed swiftly to contain outbreaks ...

  • Reuters - UK Focus13 hours ago

    Drugmakers in Davos shift focus to chronic diseases of poor

    Two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said on Wednesday they would invest an initial $50 million over three years to fight cancer and other non-communicable diseases in poor countries. Twenty-two companies, including Pfizer (NYSE: PFE - news) , Merck (Jakarta: 28586808.JK - news) , Novartis (IOB: 0QLR.IL - news) , Roche, Sanofi (LSE: 0O59.L - news) and GlaxoSmithKline (Other OTC: GLAXF - news) , will contribute funds and expertise to the project, which is backed by the World Bank. The so-called Access Accelerated initiative was announced at the World Economic Forum in Davos and aims to improve both treatment and prevention.